Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters











Database
Language
Publication year range
1.
Sci Rep ; 12(1): 1096, 2022 01 20.
Article in English | MEDLINE | ID: mdl-35058540

ABSTRACT

Manual materials handling is performed in many workplaces and is a significant risk factor for musculoskeletal injuries. The identification of lifting capacity is important to reduce the occurrence of musculoskeletal injuries. Lifting capacity is difficult to evaluate at the workplace. Therefore, there is a need to develop an alternate method that is easy and could be performed at the workplace. The study aimed to develop a lifting capacity prediction model for construction workers based on muscle strength and endurance. In this study, 65 construction workers were recruited; their socio-demographic and physical characteristics like core strength and endurance, grip strength, and lower limb flexibility were assessed. The lifting capacity was assessed using progressive isoinertial lifting evaluation. Stepwise multiple linear regression was carried out to develop the prediction model. The study suggested that age, BMI, grip strength, flexibility, prone plank, and trunk lateral flexor endurance tests have significantly influenced lifting capacity. Hence prediction model is developed using these variables. The regression model developed would help in easy estimation of lifting capacity among construction workers, which could be even administered with minimal skills by site supervisors or managers. It might help in the decision-making during pre-placement or return to work evaluations, thereby minimizing the incidence of low back disorders.


Subject(s)
Forecasting/methods , Muscle Strength/physiology , Occupational Diseases/prevention & control , Adult , Construction Industry/methods , Humans , Lifting , Male , Musculoskeletal Diseases/etiology , Musculoskeletal Diseases/physiopathology , Physical Functional Performance , Workplace
2.
J Steroid Biochem Mol Biol ; 199: 105603, 2020 05.
Article in English | MEDLINE | ID: mdl-31981799

ABSTRACT

Calcitriol, the active metabolite of vitamin D, has been widely studied for its preventive and therapeutic activity against several cancers including oral squamous cell carcinoma (OSCC). However, the impact of dietary vitamin D supplementation on initiation and progression of OSCC is unclear. To address this gap in knowledge, we conducted preclinical trials using the 4-nitroquinoline-1-oxide 4NQO carcinogen model of oral carcinogenesis. Female C57BL/6 mice were maintained on one of three vitamin D diets [25 IU, 100 IU, 10,000 IU] and exposed to 4NQO in drinking water for 16 weeks followed by regular water for 10 weeks. Body weight measurements obtained through the study duration did not reveal any differences between the three diets. Animals on 100 IU diet showed lower incidence of high-grade dysplasia/OSCC and higher CD3 + T cells compared to animals on 25 IU and 10,000 IU diets. Serum 25OHD3 levels were highest in animals on 10,000 IU diet at week 0 prior to carcinogen exposure but showed ∼50 % reduction at week 26. Histologic evaluation revealed highest incidence of OSCC in animals maintained on 10,000 IU diet. Animals on 100 IU and 10,000 IU diets showed higher vitamin D receptor VDR and CYP24A1 immunostaining in high-grade dysplastic lesions and OSCC compared to normal tongue. Validation studies performed in a 4NQO-derived OSCC model showed that short-term treatment of animals on a 25 IU diet with calcitriol significantly inhibited tumor growth compared to controls but did not affect tumor growth in animals on reference diet 1000 IU. Collectively, our results highlight the complex dynamics between vitamin D status and oral carcinogenesis. Our observations also suggest that therapeutic benefits of short-term calcitriol treatment may be more pronounced in vitamin D deficient hosts.


Subject(s)
Carcinoma, Squamous Cell/diet therapy , Mouth Neoplasms/diet therapy , Receptors, Calcitriol/genetics , Vitamin D3 24-Hydroxylase/genetics , Vitamin D/genetics , 4-Nitroquinoline-1-oxide/toxicity , Animals , Body Weight , Calcitriol/pharmacology , Carcinogenesis/drug effects , Carcinoma, Squamous Cell/blood , Carcinoma, Squamous Cell/chemically induced , Carcinoma, Squamous Cell/pathology , Dietary Supplements/adverse effects , Disease Models, Animal , Disease Progression , Humans , Mice , Mouth Neoplasms/blood , Mouth Neoplasms/chemically induced , Mouth Neoplasms/pathology , Vitamin D/blood , Vitamin D Deficiency/diet therapy , Vitamin D Deficiency/genetics , Vitamin D Deficiency/pathology
3.
Int J Telemed Appl ; 2019: 5903106, 2019.
Article in English | MEDLINE | ID: mdl-31186627

ABSTRACT

BACKGROUND: Stroke is a leading cause of disability and requires continued care after hospital discharge. Mobile-based interventions are suitable to reduce the cost of stroke rehabilitation and facilitate self-management among stroke survivors. However, before attempting to use mobile-based home exercise program, it is crucial to recognize the readiness of stroke survivors and their caregivers to opt for such interventions. OBJECTIVE: To assess the acceptability and attitude towards a mobile-based home exercise program among stroke survivors and their primary caregivers. METHODS: A cross-sectional study was conducted among 102 participants to understand their attitude and acceptability towards mobile-based home exercise program. A validated 10-item questionnaire was adapted for the study. The questions which assessed the attitude were rated on a three-point Likert scale, with three denoting agree and one denoting disagree. The acceptability was assessed by their willingness to opt for a mobile-based home program services. A Chi-square analysis and cross-tabulation were performed to test differences between caregivers and patients. A logistic regression was performed to determine the effects of age, gender, and mobile phone on acceptability. RESULTS: Ninety-two percent of caregivers and 90% of patients showed willingness to opt for mobile-based intervention. Majority of the participants showed a positive attitude towards this mode of treatment. There was no difference in the attitude noted among caregivers and patients (p>0.05) towards mobile-based intervention. CONCLUSION: The stroke survivors and caregivers welcomed the concept of mobile-based home exercise program even in a low-resource settings, but further studies to understand treatment and cost-effectiveness of this technology among the stroke survivors would lead to better implementation.

4.
J Oral Pathol Med ; 47(5): 484-491, 2018 May.
Article in English | MEDLINE | ID: mdl-29573032

ABSTRACT

BACKGROUND: The antidiabetic drug metformin (Met) is believed to inhibit tumor proliferation by altering the metabolism of cancer cells. In this study, we examined the effects of Met on tumor oxygenation, metabolism, and growth in head and neck squamous cell carcinoma (HNSCC) using non-invasive multimodal imaging. MATERIALS AND METHODS: Severe combined immunodeficient (SCID) mice bearing orthotopic FaDu HNSCC xenografts were treated with Met (200 mg/kg, ip) once daily for 5 days. Tumor oxygen saturation (%sO2 ) and hemoglobin concentration (HbT) were measured using photoacoustic imaging (PAI). Fluorescence imaging was employed to measure intratumoral uptake of 2-deoxyglucosone (2-DG) following Met treatment while magnetic resonance imaging (MRI) was utilized to measure tumor volume. Correlative immunostaining of tumor sections for markers of proliferation (Ki67) and vascularity (CD31) was also performed. RESULTS: At 5 days post-Met treatment, PAI revealed a significant increase (P < .05) in %sO2 and HbT levels in treated tumors compared to untreated controls. Fluorescence imaging at this time point revealed a 46% decrease in mean 2-DG uptake compared to controls. No changes in hemodynamic parameters were observed in mouse salivary gland tissue. A significant decrease in Ki-67 staining (P < .001) and MR-based tumor volume was also observed in Met-treated tumors compared to controls with no change in CD31 + vessel count following Met therapy. CONCLUSION: Our results provide, for the first time, direct in vivo evidence of Met-induced changes in tumor microenvironmental parameters in HNSCC xenografts. Our findings highlight the utility of multimodal functional imaging for non-invasive mapping of the effects of Met in HNSCC.


Subject(s)
Carcinoma, Squamous Cell/diagnostic imaging , Carcinoma, Squamous Cell/metabolism , Head and Neck Neoplasms/diagnostic imaging , Head and Neck Neoplasms/metabolism , Hypoglycemic Agents/pharmacology , Metformin/pharmacology , Multimodal Imaging , Animals , Carcinoma, Squamous Cell/blood supply , Carcinoma, Squamous Cell/pathology , Cell Proliferation , Female , Head and Neck Neoplasms/blood supply , Head and Neck Neoplasms/pathology , Hemoglobins/metabolism , Ki-67 Antigen/metabolism , Metformin/administration & dosage , Mice, SCID , Neoplasm Transplantation , Oxygen/metabolism , Platelet Endothelial Cell Adhesion Molecule-1/metabolism , Squamous Cell Carcinoma of Head and Neck , Tumor Microenvironment/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL